Home / Contract Awards / Lockheed Delivers C-130J to Israel and 3rd F-35 to the U.K.; George Shultz Comments

Lockheed Delivers C-130J to Israel and 3rd F-35 to the U.K.; George Shultz Comments

lockheed martinLockheed Martin (NYSE: LMT) has delivered the first of three C-130J super Hercules’ for Israel’s Air Force under a U.S. foreign military sales agreement, the company said Wednesday.

The delivery occurred at a Wednesday ceremony at Lockheed’s facility in Marietta, Ga. The airlifter will now undergo modifications to include Israel-made systems.

George Shultz, vice president and general manager of C-130 programs at the Lockheed’s aeronautics business, said the C-130J features glass cockpit and digital technology designed for missions in all kinds of environment.

MP13-0603 Israel C-130J Delivery CeremonyThe C-130J worldwide fleet has recently achieved a milestone of flying 1 million hours, according to the company.

The aircraft is expected to be delivered in-country in Spring 2014 and is being called Shimshon, Hebrew for Samson,  by the Israeli Air Force. 

In a separate statement, Lockheed announced it has delivered its third F-35 short takeoff and vertical landing fighter jet to the U.K. Air Force.

The F35B variant arrived at Eglin Air Force Base in Florida Tuesday for pilot and maintenance crew training.

Lockheed has collaborated with BAE Systems and Northrop Grumman on the U.K.’s Lightning II program.

The company says more than 500 U.K. suppliers, including General Electronic‘s aviation business unit, will be responsible for 15 percent of work on each F35.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.